Therapeutic Enhancement of Protective Immunity during Experimental Leishmaniasis
Leishmaniasis is an infectious disease that causes a large burden of morbidity and mortality in the tropics. Caused by protozoan parasites of the genus Leishmania that are transmitted by sandflies, leishmaniasis causes a wide spectrum of human disease. The severe end of the spectrum, visceral leishm...
Main Authors: | Divanovic, Senad, Trompette, Aurelien, Ashworth, Jamie I., Rao, Marepalli B., Karp, Christopher L. |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3167777/ |
Similar Items
-
Therapeutic effect of ursolic acid in experimental visceral leishmaniasis
by: Jesus, Jéssica A., et al.
Published: (2016) -
Protective Immunity and Vaccination Against Cutaneous Leishmaniasis
by: Okwor, Ifeoma, et al.
Published: (2012) -
Protective and pathologic immune responses in human tegumentary leishmaniasis
by: Carvalho, Lucas P., et al.
Published: (2012) -
Therapeutic Options for Visceral Leishmaniasis
by: Monge-Maillo, Begoña, et al.
Published: (2013) -
Enhanced Mucosal Antibody Production and Protection against Respiratory Infections Following an Orally Administered Bacterial Extract
by: Pasquali, Christian, et al.
Published: (2014)